Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase i and II trials

European Journal of Surgical Oncology

Volumn 36, Issue 10, 2010, Pages 997-1003

  Kluger, M D ^a   Taub, R N ^a   Hesdorffer, M ^a   Jin, Z ^b   Chabot, J A ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Columbia University ^*  (United States)

Author keywords

Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Malignant abdominal mesothelioma; Peritoneal surface malignancy; Peritonectomy

Indexed keywords

CISPLATIN; DOXORUBICIN; GAMMA INTERFERON; GAMMA INTERFERON 1B; GEMCITABINE; HEPARIN; MITOMYCIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ABDOMINAL SURGERY; ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPIRATION PNEUMONIA; BACTEREMIA; BLEEDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLOSTRIDIUM DIFFICILE INFECTION; CYTOREDUCTIVE SURGERY; DEHYDRATION; DIFFUSE MALIGNANT PERITONEAL MESOTHELIOMA; ENTEROCUTANEOUS FISTULA; FEMALE; HOSPITAL DISCHARGE; HUMAN; ILEUS; INFECTION COMPLICATION; INTRAPERITONEAL CHEMOTHERAPY; LENGTH OF STAY; LUNG EDEMA; MALE; MEDICAL RECORD; MORBIDITY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PANCREATITIS; PERITONECTOMY; PERITONEUM MESOTHELIOMA; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPTIC SHOCK; SURGICAL INFECTION; SURGICAL MORTALITY; TWO STAGE OPERATIVE CYTOREDUCTION; URINARY TRACT INFECTION; CANCER STAGING; CAUSE OF DEATH; CLINICAL TRIAL; COMPARATIVE STUDY; FACTUAL DATABASE; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; KAPLAN MEIER METHOD; LAPAROTOMY; MESOTHELIOMA; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEEDLE BIOPSY; NONPARAMETRIC TEST; PATHOLOGY; PERITONEAL NEOPLASMS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; REOPERATION; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME; TUMOR INVASION; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CAUSE OF DEATH; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; KAPLAN-MEIERS ESTIMATE; LAPAROTOMY; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEW YORK CITY; PERITONEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; REOPERATION; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; KAPLAN-MEIER ESTIMATE;

EID: 77957155401     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.07.001     Document Type: Article

References (28)

1. T. Larson, N. Melnikova, S.I. Davis, and P. Jamison Incidence and descriptive epidemiology of mesothelioma in the United States, 1999-2002 Int J Occup Environ Health 13 4 2007 398 403
2. T.D. Yan, L. Welch, D. Black, and P.H. Sugarbaker A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma Ann Oncol 18 5 2007 May 827 834
3. B.J. Park, H.R. Alexander, and S.K. Libutti Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP) Ann Surg Oncol 6 6 1999 582 590
4. G.H. Eltabbakh, M.S. Piver, and R.E. Hempling Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma J Surg Oncol 70 1 1999 Jan 6 12
5. T.D. Yan, G. Edwards, and R. Alderman Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma - a prospective study of 70 consecutive cases Ann Surg Oncol 14 2 2007 Feb 515 525
6. M. Deraco, D. Nonaka, and D. Baratti Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion Ann Surg Oncol 13 2 2006 229 237
7. B.W. Loggie, R.A. Fleming, and R.P. McQuellon Prospective trial for the treatment of malignant peritoneal mesothelioma Am Surg 67 10 2001 999 1003
8. C. Brigand, O. Monneuse, and F. Mohamed Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study Ann Surg Oncol 13 3 2006 405 412
9. M.E. Hesdorffer, J.A. Chabot, and M.L. Keohan Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma Am J Clin Oncol 31 2008 49 54
10. A.L. Feldman, S.K. Libutti, and J.F. Pingpank Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy J Clin Oncol 21 24 2003 4560 4567
11. P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1 1995 29 42
12. J.A. Wagmiller, M. Keohan, and J.A. Chabot Peritoneal mesothelioma: the Columbia experience H.I. Pass, N.J. Vogelzang, M. Carbone, Malignant mesothelioma: advances in pathogenesis, diagnosis and translational therapies 2005 Springer New York 723 731
13. S. Gonzalez-Moreno Peritoneal surface oncology: a progress report Eur J Surg Oncol 32 6 2006 593 596
14. L.B. Monegro, J.R. Beck, and R.M. Kroslowitz Treatment of primary peritoneal mesothelioma by hyperthermic intraperitoneal chemotherapy Perfusion 14 1999 141 145
15. D. Dindo, N. Demartines, and P. Clavien Classification of surgical complications. a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2 2004 205 213
16. S.F. Khuri, J. Daley, and W. Henderson The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program Ann Surg 228 1998 491 507
17. P. Jacquet, and P.H. Sugarbaker Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis P.H. Sugarbaker, Peritoneal carcinomatosis: principles of management 1996 Kluwer Academic Publishers Boston 359 374
18. K. Antman, R. Shemin, and L. Ryan Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham an Women's Hospital experience over two decades, 1965-1985 J Clin Oncol 6 1988 147 153
19. A.P. Chahinian, K. Antman, and M. Goutsou Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B J Clin Oncol 11 1993 1559 1565
20. C. Boutin, E. Nussbaum, and I. Monnet Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma Cancer 74 1994 2460 2467
21. G. Los, P.H. Mutsaers, and W.J. van der Vijgh Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy Cancer Res 49 1989 3380 3384
22. G. Los, E.M. Verdegaal, P.H. Mutsaers, and J.G. McVie Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy Cancer Chemother Pharmacol 28 1991 159 165
23. R.K. Jain Transport of molecules in the tumor interstitium: a review Cancer Res 47 1987 3039 3051
24. T.D. Yan, E.A. Brun, and C.A. Cerruto Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma Ann Surg Oncol 14 2007 41 49
25. M. Deraco, D. Bartlett, S. Kusamura, and D. Baratti Consensus statement on peritoneal DMPM J Surg Oncol 98 2008 268 272
26. D. Baratti, S. Kusamura, A.D. Cabras, B. Laterza, M.R. Balestra, and M. Deraco Lymph node Metastases in diffuse malignant peritoneal mesothelioma Ann Surg Oncol 17 2010 45 53
27. T.D. Yan, D. Yoo, and P.H. Sugarbaker Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma Eur J Surg Oncol 32 2006 948 953
28. S. Gonzalez-Moreno, S. Kusamura, D. Baratti, and M. Deraco Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy J Surg Oncol 98 2008 237 241